HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideaki Ichihara Selected Research

diethanolamine

1/2019Therapeutic effects and anti-metastasis effects of cationic liposomes against pancreatic cancer metastasis in vitro and in vivo.
1/2014Therapeutic effects of cationic hybrid liposomes on the hepatic metastasis of colon carcinoma along with apoptosis in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideaki Ichihara Research Topics

Disease

15Neoplasms (Cancer)
11/2018 - 02/2006
11Carcinoma (Carcinomatosis)
11/2017 - 01/2003
8Neoplasm Metastasis (Metastasis)
01/2019 - 04/2009
5Breast Neoplasms (Breast Cancer)
11/2020 - 05/2009
4Colorectal Neoplasms (Colorectal Cancer)
11/2018 - 11/2012
3Rheumatoid Arthritis
07/2015 - 01/2011
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 01/2018
2Arthritis (Polyarthritis)
07/2015 - 01/2011
2Lymphoma (Lymphomas)
04/2009 - 03/2008
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2016
1Experimental Arthritis
07/2015
1Osteosarcoma (Osteogenic Sarcoma)
06/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Carcinogenesis
01/2012
1Leukemia
03/2011
1Alzheimer Disease (Alzheimer's Disease)
01/2011
1Neuroblastoma
01/2011
1Renal Cell Carcinoma (Grawitz Tumor)
02/2010
1Necrosis
02/2006
1Melanoma (Melanoma, Malignant)
01/2003

Drug/Important Bio-Agent (IBA)

27Liposomes (Liposome)IBA
11/2020 - 01/2003
20Therapeutic UsesIBA
01/2019 - 04/2009
17Dimyristoylphosphatidylcholine (DMPC)IBA
11/2020 - 01/2003
5Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2019 - 04/2009
5Ether (Diethyl Ether)IBA
01/2019 - 04/2009
5Pharmaceutical PreparationsIBA
11/2018 - 04/2009
4polyoxyethylene(25)dodecyl etherIBA
10/2018 - 11/2012
3TrehaloseIBA
11/2020 - 01/2016
3polyoxyethylene (23) dodecyletherIBA
07/2015 - 02/2006
2diethanolamineIBA
01/2019 - 01/2014
2ChloridesIBA
01/2019 - 01/2014
2Fluorescent Dyes (Fluorescent Probes)IBA
11/2018 - 10/2018
2Hematoxylin (Haematoxylon)IBA
11/2017 - 07/2010
2Eosine Yellowish-(YS) (Eosin)IBA
11/2017 - 07/2010
2Surface-Active Agents (Surfactants)IBA
01/2016 - 04/2009
2Phosphatidylcholines (Phosphatidylcholine)IBA
01/2014 - 01/2011
2Trastuzumab (Herceptin)FDA Link
01/2013 - 01/2012
2human ERBB2 proteinIBA
01/2013 - 01/2012
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2011 - 02/2006
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1GlycosphingolipidsIBA
01/2018
1PhosphatidylserinesIBA
01/2018
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2018
1Biotin (Vitamin H)FDA Link
11/2016
1CytokinesIBA
07/2015
1deoxyuridine triphosphateIBA
01/2013
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2013
1PowdersIBA
01/2012
1Unithiol (DMPS)IBA
01/2011
1Docosahexaenoic AcidsIBA
01/2011
1Amyloid (Amyloid Fibrils)IBA
01/2011
1Ammonium CompoundsIBA
01/2011
1Peptides (Polypeptides)IBA
01/2011
1PropaneIBA
01/2011
1dimyristoylphosphatidylserineIBA
01/2011
1Polidocanol (Laureth)FDA Link
01/2003

Therapy/Procedure

8Drug Therapy (Chemotherapy)
01/2018 - 10/2008
4Intravenous Injections
01/2014 - 07/2010
3Aftercare (After-Treatment)
09/2014 - 03/2008
2Intravenous Administration
11/2018 - 10/2018
2Precision Medicine
11/2018 - 10/2018
1Immunotherapy
01/2012
1Oral Administration
01/2012